CardiacSense has developed a wearable for continuously monitoring vital signs of either inpatients or outpatients. The CardiacSense watch and wristband can measure core temperature, heart rate, respiratory rate, SpO2, and cuff-less blood pressure and detect arrythmia, the company reported in a news release. Such monitoring could monitor isolated patients as well as those recovering at home.
"We have aleady submitted the files for FDA and CE and [are] now waiting for the review," Eyal Copitt, chief commercial officer for CardiacSense, told MD+DI. "The first submission was for HR, HRV, Spot ECG, A-fib detection. Submission for respiratory rate is expected to be submitted by July, and submission for SpO2 and blood pressure for December."
Featuring wireless communication, the CardiacSense device can send real-time measurements to medical staff and receive back written instructions through the device screen whether the patient being in the hospital or at home, the company reported.